We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TLS:NASDAQTelos Corporation Analysis

Data as of 2026-05-27 - not real-time

$4.69

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Telos Corp (TLS) posted a 55.9% YoY revenue surge to $181.9M, beating estimates and driving an increasing volume trend. The Q1 earnings beat consensus, delivering $0.06 EPS versus a loss a year ago, and management highlighted strategic share repurchases despite recent leadership changes. Technicals show a bullish MACD (0.076 above signal) and an RSI of ~60, keeping momentum neutral‑to‑positive, while the price sits near the $4.88 resistance above the $4.05 support. The stock trades at a forward P/E of 18, well below the software‑infrastructure industry average of 40.6, and the DCF model assigns a fair value of $12.46, implying a ~45% upside.
However, the company still reports a ‑14% profit margin, negative EBITDA and a high debt‑to‑equity of 7.8, which together with a beta of 1.94 and 30‑day volatility of 51% raise the risk profile. The lack of dividend and modest cash balance of $50.2M relative to debt further constrain defensive appeal. Given the strong top‑line growth, attractive valuation multiples and bullish technical signals, the stock presents a high‑conviction upside play, albeit with heightened volatility and leverage concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD and rising volume support near‑term price stability
  • Price near resistance at $4.88 with support at $4.05
  • Recent earnings beat and strong revenue growth

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates ~45% upside
  • Forward P/E of 18 versus industry average of 40
  • Continued top‑line momentum and strategic share repurchases

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High beta (1.94) and 30‑day volatility of 51% increase market risk
  • Elevated debt‑to‑equity ratio (7.8) raises leverage concerns
  • Secular demand for cyber and identity security solutions

Key Metrics & Analysis

Financial Health

Revenue Growth55.90%
Profit Margin-14.25%
P/E Ratio18.0
ROE-23.28%
ROA-5.87%
Debt/Equity7.80
P/B Ratio3.6
Op. Cash Flow$32.7M
Free Cash Flow$25.0M
Industry P/E40.6

Technical Analysis

TrendNeutral
RSI59.9
Support$4.05
Resistance$4.88
MA 20$4.40
MA 50$4.32
MA 200$5.41
MACDBullish
VolumeIncreasing
Fear & Greed Index91.05

Valuation

Fair Value$12.46
Target Price$6.83
Upside/Downside45.70%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.94
Volatility51.12%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.